These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 29655782

  • 1. Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness.
    Mikó E, Vida A, Kovács T, Ujlaki G, Trencsényi G, Márton J, Sári Z, Kovács P, Boratkó A, Hujber Z, Csonka T, Antal-Szalmás P, Watanabe M, Gombos I, Csoka B, Kiss B, Vígh L, Szabó J, Méhes G, Sebestyén A, Goedert JJ, Bai P.
    Biochim Biophys Acta Bioenerg; 2018 Sep; 1859(9):958-974. PubMed ID: 29655782
    [Abstract] [Full Text] [Related]

  • 2. Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells.
    Luu TH, Bard JM, Carbonnelle D, Chaillou C, Huvelin JM, Bobin-Dubigeon C, Nazih H.
    Cell Oncol (Dordr); 2018 Feb; 41(1):13-24. PubMed ID: 28993998
    [Abstract] [Full Text] [Related]

  • 3. The synthesis and antitumor activity of lithocholic acid and its derivatives.
    He XL, Xing Y, Gu XZ, Xiao JX, Wang YY, Yi Z, Qiu WW.
    Steroids; 2017 Sep; 125():54-60. PubMed ID: 28648585
    [Abstract] [Full Text] [Related]

  • 4. Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells.
    Goldberg AA, Beach A, Davies GF, Harkness TA, Leblanc A, Titorenko VI.
    Oncotarget; 2011 Oct; 2(10):761-82. PubMed ID: 21992775
    [Abstract] [Full Text] [Related]

  • 5. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
    Ward JBJ, Lajczak NK, Kelly OB, O'Dwyer AM, Giddam AK, Ní Gabhann J, Franco P, Tambuwala MM, Jefferies CA, Keely S, Roda A, Keely SJ.
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun 01; 312(6):G550-G558. PubMed ID: 28360029
    [Abstract] [Full Text] [Related]

  • 6. Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors.
    Kovács T, Mikó E, Vida A, Sebő É, Toth J, Csonka T, Boratkó A, Ujlaki G, Lente G, Kovács P, Tóth D, Árkosy P, Kiss B, Méhes G, Goedert JJ, Bai P.
    Sci Rep; 2019 Feb 04; 9(1):1300. PubMed ID: 30718646
    [Abstract] [Full Text] [Related]

  • 7. Lithocholic bile acid induces apoptosis in human nephroblastoma cells: a non-selective treatment option.
    Trah J, Arand J, Oh J, Pagerols-Raluy L, Trochimiuk M, Appl B, Heidelbach H, Vincent D, Saleem MA, Reinshagen K, Mühlig AK, Boettcher M.
    Sci Rep; 2020 Nov 23; 10(1):20349. PubMed ID: 33230229
    [Abstract] [Full Text] [Related]

  • 8. Lithocholic Acid Improves the Survival of Drosophila Melanogaster.
    Staats S, Rimbach G, Kuenstner A, Graspeuntner S, Rupp J, Busch H, Sina C, Ipharraguerre IR, Wagner AE.
    Mol Nutr Food Res; 2018 Oct 23; 62(20):e1800424. PubMed ID: 30051966
    [Abstract] [Full Text] [Related]

  • 9. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
    Jia L, Huang S, Yin X, Zan Y, Guo Y, Han L.
    Life Sci; 2018 Sep 01; 208():123-130. PubMed ID: 30025823
    [Abstract] [Full Text] [Related]

  • 10. Proliferative effect of lithocholic acid on rat liver cell in culture.
    Jeannin JF, Chessebeuf M, Martin MS, Lagneau A, Martin F.
    Biomedicine; 1979 Nov 01; 31(7):207-9. PubMed ID: 526544
    [Abstract] [Full Text] [Related]

  • 11. Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis.
    Ruiz-Gaspà S, Dubreuil M, Guañabens N, Combalia A, Peris P, Monegal A, Parés A.
    Eur J Clin Invest; 2014 Dec 01; 44(12):1206-14. PubMed ID: 25331234
    [Abstract] [Full Text] [Related]

  • 12. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
    Liu J, Chen X, Ward T, Pegram M, Shen K.
    Tumour Biol; 2016 Jul 01; 37(7):9825-35. PubMed ID: 26810188
    [Abstract] [Full Text] [Related]

  • 13. Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis.
    Du J, Sun Y, Lu YY, Lau E, Zhao M, Zhou QM, Su SB.
    Anticancer Res; 2017 Nov 01; 37(11):6141-6151. PubMed ID: 29061795
    [Abstract] [Full Text] [Related]

  • 14. Polyporus umbellatus inhibited tumor cell proliferation and promoted tumor cell apoptosis by down-regulating AKT in breast cancer.
    Tan XL, Guo L, Wang GH.
    Biomed Pharmacother; 2016 Oct 01; 83():526-535. PubMed ID: 27447121
    [Abstract] [Full Text] [Related]

  • 15. Extrahepatic deposition and cytotoxicity of lithocholic acid: studies in two hamster models of hepatic failure and in cultured human fibroblasts.
    Ceryak S, Bouscarel B, Malavolti M, Fromm H.
    Hepatology; 1998 Feb 01; 27(2):546-56. PubMed ID: 9462656
    [Abstract] [Full Text] [Related]

  • 16. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
    Wang L, Wang Y, Du H, Jiang Y, Tang Z, Liu H, Xiang H, Xiao H.
    Cancer Chemother Pharmacol; 2015 Dec 01; 76(6):1247-57. PubMed ID: 26464351
    [Abstract] [Full Text] [Related]

  • 17. Raddeanoside R13 inhibits breast cancer cell proliferation, invasion, and metastasis.
    Liang Y, Xu X, Yu H, Li L, Hong T, Ji Q, Feng Y, Jin S, Song Y, Guo J, Zheng Z, Ye Q, Yang S.
    Tumour Biol; 2016 Jul 01; 37(7):9837-47. PubMed ID: 26810189
    [Abstract] [Full Text] [Related]

  • 18. Ginsenoside Rd regulates the Akt/mTOR/p70S6K signaling cascade and suppresses angiogenesis and breast tumor growth.
    Zhang E, Shi H, Yang L, Wu X, Wang Z.
    Oncol Rep; 2017 Jul 01; 38(1):359-367. PubMed ID: 28534996
    [Abstract] [Full Text] [Related]

  • 19. Expression of 3β-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status.
    Chang YC, Chen CK, Chen MJ, Lin JC, Lin CH, Huang WC, Cheng SP, Chen SN, Liu CL.
    Ann Surg Oncol; 2017 Dec 01; 24(13):4033-4041. PubMed ID: 28744792
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis, and mechanistic investigations of bile acid-tamoxifen conjugates for breast cancer therapy.
    Sreekanth V, Bansal S, Motiani RK, Kundu S, Muppu SK, Majumdar TD, Panjamurthy K, Sengupta S, Bajaj A.
    Bioconjug Chem; 2013 Sep 18; 24(9):1468-84. PubMed ID: 23909664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.